What's Next at Paragonix?
Paragonix Technologies is continually innovating in order to provide every possible advantage to transplant patients worldwide.
What's Next at Paragonix?
Paragonix Technologies is continually innovating in order to provide every possible advantage to transplant patients worldwide.
Organ Transplantation Has Unmet Patient Needs
Organ Transplantation Has Unmet Patient Needs
Organ Transplantation Has Unmet Patient Needs
Demand exceeds supply of donor organs1
Post-op failure rates2,3
Up to 40% of patients
High rejection rates4,5
50% of organs rejected within 10 years
US donor organs travel farther6,7
US policy changes ensure sickest patients receive priority
At Paragonix, We're Looking to the Future
Next Generation Products
SherpaPak
SherpaPak
Pancreas Transport System
Coming Soon
FDA cleared
CE Mark
SherpaPak
SherpaPak
Kidney Transport System
Coming Soon
FDA cleared
CE Mark
BAROguard
BAROguard
Lung Preservation System
In Development
FDA pending
CE Mark
CardiOvault
CardiOvault
Cardiac Transport System
In Development
FDA pending
CE Mark
- Lewis, Amy, et al. “Organ donation in the US and Europe: The supply vs demand imbalance.” Transplantation Reviews 35.2 (2021): 100585.
- Hemmert, C., et al. “Imaging of lung transplant complications.” Diagnostic and interventional imaging 95.4 (2014): 399-409.
- Hoy, Samantha, and Jason Frisbee. “Common Postoperative Heart Transplant Complications.” Critical care nursing quarterly 41.4 (2018): 383-388.
- Hemmert, C., et al. “Imaging of lung transplant complications.” Diagnostic and interventional imaging 95.4 (2014): 399-409.
- Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, et al. Registry of the international society for heart and lung transplantation: Twenty-sixth official adult heart transplant report–2009. J Heart Lung Transplant 2009; 28: 1007–1022
- OPTN Thoracic Transplantation Committee. “One-year monitoring of heart allocation proposal to modify the heart allocation system.” (2020).
- Goff, R. R., and A. Wilk. “Monitoring of the Lung Allocation Change, 2 Year Report; Removal of DSA as a Unit of Allocation.” (2020).
